“Conversion Therapy for Advanced Hepatocellular Carcinoma Following Complete Response to Transarterial Radioembolization Combined With Atezolizumab and Bevacizumab”. 2026. Radiology and Oncology 60 (1): 40-48. https://www.ojstest.computing.si/index.php/ro/article/view/4783.